Bullish Moving Averages
16
Bearish Moving Averages
0
Back Stocks profile
Stock analysis tool for investors
Open an Account with Bigul in 5 minutes
Performance
Open Price
144.50Prev. Close
119.4500Volume
27373664.00Value
4134791947.20Fundamentals
Market Cap Cr
19984.30
Price to Earnings
-599.40
Price to Book Value
3.00
Dividend Yield
0.00
PE to Growth
234.50
Op Revenue TTM Cr
7782.38
Net Profit TTM Cr
-33.34
Cash From Operating Activity Cr
483.89
Return on Equity %
-2.75
EMA & SMA
DELIVERY AND VOLUME
DAILY AVG. DELIVERY VOLUME %
03 May, 2024
29.6
Week
34.3
Month
41.6
LEGEND
Positive Indicator
Neutral Indicator
Negative Indicator
RESISTANCE AND SUPPORT
149.40
PIVOT
First Resistance
155.55
Second Resistance
160.05
Third Resistance
166.20
First Support
144.90
Second Support
138.75
Third Support
134.25
Relative Strength Index
70.54
Money Flow Index
76.28
MACD
3.83
MACD Signal
3.36
Average True Range
4.97
Average Directional Index
26.78
Rate of Change (21)
16.28
Rate of Change (125)
44.55
Commodity Channel Index
235.3
Williams %R
-14.1
BETA
1 Month
0.14
3 Month
0.85
1 Year
0.45
3 Year
PRICE CHANGE ANALYSIS
↑ 6.19%
1 Week
Low
High
141.35
153.9
↑ 10.98%
1 Month
Low
High
133.55
153.9
↑ 9.73%
3 Months
Low
High
114.35
153.9
↑ 44.34%
6 Months
Low
High
95.3
153.9
↑ 111.32%
1 Year
Low
High
69.14
153.9
30 Apr 2024
Piramal Pharma Ltd - 543635 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Intimation of Conference Call with Investor/Analysts under the SEBI (Listing Obligation and Disclosure Requirements) Regulation, 2015.
30 Apr 2024
Piramal Pharma Ltd - 543635 - Board Meeting Intimation for Board Meeting Intimation As Per Regulation 29 Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015 ('Listing Regulations')
Piramal Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/05/2024 ,inter alia, to consider and approve the Audited Financial Results (Standalone and Consolidated) for the financial year ended 31st March 2024 and to consider recommending payment of dividend to the shareholders.
27 Apr 2024
Piramal Pharma Ltd - 543635 - Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015, As Amended ('SEBI Listing Regulations')
Disclosure under Regualtion 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amednded (''SEBI Listing Regulations'')
19 Apr 2024
Piramal Pharma Ltd - 543635 - Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015, As Amended ('SEBI Listing Regulations')
Disclsoure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended (''SEBI Listing Regulations'')
18 Apr 2024
Piramal Pharma Ltd - 543635 - Compliance Certificate Pursuant To Regulation 40(10) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 ('Listing Regulations')
Compliance Certificate pursuant to Regulation 40(10) of the SEBI Listing Regulations.
18 Apr 2024
Piramal Pharma Ltd - 543635 - Compliance Certificate Pursuant To Regulation 7(3) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 ('Listing Regulations') For The Financial Year Ended 31St March, 2024
Compliance Certificate pursuant to Regulation 7(3) of the Listing Regulations for financial year ended 31st March, 2024.
17 Apr 2024
Piramal Pharma Ltd - 543635 - Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 - Successful Closure Of US FDA Inspection At Piramal Pharma'S Manufacturing Facility Located At Riverview, USA
Successful closure of US FDA Inspection at Piramal Pharma''s manufacturing facility located at Riverview, USA
10 Apr 2024
Piramal Pharma forays into men's grooming with BOHEM
This includes a hair removal spray, a beard growth oil, and an underarm roll-on, the company said, adding that BOHEM drew from Bohemian' signifying unconventional identity or lifestyle
10 Apr 2024
Piramal Pharma Ltd - 543635 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Press Release- Piramal Pharma Limited (''the Company'') forays into men''s grooming market with the launch of BOHEM.
02 Apr 2024
Buy Piramal Pharma; target of Rs 171: Asit C Mehta
Asit C Mehta is bullish on Piramal Pharma has recommended buy rating on the stock with a target price of Rs 171 in its research report dated April 01 2024.
